Targeting S100A1 in heart failure

Gene Therapy
Julia Ritterhoff, Patrick Most

Abstract

Heart failure (HF) is the common endpoint of many cardiovascular diseases with a 1-year survival rate of about 50% in advanced stages. Despite increasing survival rates in the past years, current standard therapeutic strategies are far away from being optimal. For this reason, the concept of cardiac gene therapy for the treatment of HF holds great potential to improve disease progression, as it specifically targets key pathologies of diseased cardiomyocytes (CM). The small calcium (Ca(2+))-binding protein S100A1 presents a promising target for cardiac gene therapy, as it has been identified as a central regulator of cardiac performance and the Ca(2+)-driven network within CM. S100A1 was shown to regulate sarcoplasmic reticulum, sarcomere and mitochondrial function by modulating target protein activity. Furthermore, deranged S100A1 expression has been linked to HF in human ischemic and dilated cardiomyopathies as well as in various HF animal models. Proof-of-concept studies in small and large animal models as wells as in human failing CM could demonstrate feasibility and efficacy of S100A1 genetically targeted therapy. This review summarizes the developmental steps of S100A1 gene therapy for the implementation into first human c...Continue Reading

References

Aug 1, 1991·Brain Research Bulletin·D B ZimmerW E Zimmer
Oct 17, 1985·Biochimica Et Biophysica Acta·K Kato, S Kimura
Oct 11, 1996·Biochimica Et Biophysica Acta·A RemppisC W Heizmann
Apr 4, 2000·Circulation Research·R J HajjarA Rosenzweig
Dec 8, 2000·Biochimica Et Biophysica Acta·R KiewitzC W Heizmann
Nov 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·P MostA Remppis
Mar 23, 2002·Molecular and Cellular Biology·Xiao-Jun DuJörg Heierhorst
May 7, 2002·Frontiers in Bioscience : a Journal and Virtual Library·Claus W HeizmannBeat W Schäfer
Oct 24, 2002·Journal of Molecular and Cellular Cardiology·Robert S Balaban
Jan 14, 2003·Annual Review of Physiology·N Frey, E N Olson
Mar 8, 2003·Circulation Research·Steven R Houser, Kenneth B Margulies
Mar 20, 2003·Microscopy Research and Technique·Rosario Donato
Mar 20, 2003·Microscopy Research and Technique·Danna B ZimmerDavid J Weber
May 14, 2003·Journal of the American College of Cardiology·Mandeep R MehraGary S Francis
May 15, 2003·Molecular Membrane Biology·J Alfonso LeyvaL Mario Amzel
Jun 14, 2003·Biochemical and Biophysical Research Communications·Roland KiewitzClaus W Heizmann
Sep 1, 2004·Biochemical and Biophysical Research Communications·Ingo MarenholzGünter Fritz
Dec 4, 2004·The Journal of Clinical Investigation·Patrick MostWalter J Koch
Dec 14, 2004·Biochimica Et Biophysica Acta·Liliya ZhukovaAleksandra Wyslouch-Cieszynska
May 12, 2005·The FEBS Journal·Grazyna GochAndrzej Bierzyñski
Sep 20, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sven T PlegerPatrick Most
Sep 20, 2005·Journal of Molecular Biology·Nathan T WrightDavid J Weber
Oct 21, 2005·Journal of Molecular and Cellular Cardiology·S KettlewellG L Smith
May 11, 2006·The Biochemical Journal·Liliana Santamaria-KisielGary S Shaw
Aug 15, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Martin M LeWinterHenk Granzier
Apr 18, 2007·Molecular and Cellular Biology·Melanie BoerriesCora-Ann Schoenenberger
Jun 15, 2007·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·I SalamaJ L Jones
Nov 9, 2007·Annual Review of Physiology·Donald M Bers
Feb 23, 2008·Circulation Research·Sven T PlegerPatrick Most
Jun 21, 2008·Circulation Research·Leif Erik VingeWalter J Koch
Mar 17, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Jean-Francois DesjardinsThomas G Parker
Mar 31, 2009·Journal of Cardiac Failure·Brian E JaskiUNKNOWN Calcium Up-Regulation by Percutaneous Administration of Gene Therapy In Cardiac Disease (CUPID) Trial Investigators

❮ Previous
Next ❯

Citations

Jul 3, 2013·Cellular and Molecular Life Sciences : CMLS·Stephane R GrossPhilip S Rudland
Sep 25, 2015·Future Medicinal Chemistry·Bianca C BernardoJulie R McMullen
Mar 19, 2014·Journal of Molecular and Cellular Cardiology·Wang WangJoseph M Metzger
Apr 17, 2015·The Journal of Pharmacy and Pharmacology·Jiangkun YuLeiming Wu
May 26, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Julia RitterhoffPatrick Most
Dec 4, 2014·Lancet·Eugene Braunwald
Oct 2, 2012·Biochimica Et Biophysica Acta·Michelle L AspJoseph M Metzger
Jul 21, 2016·The International Journal of Biochemistry & Cell Biology·Michaela JirkuKristyna Bousova
Feb 25, 2017·Stem Cells·Caressa ChenIoannis Karakikes
Aug 31, 2013·Circulation Research·Sven T PlegerPatrick Most
Jul 28, 2013·Circulation Research·Eugene Braunwald
Dec 15, 2017·The FEBS Journal·Kristyna BousovaJan Teisinger
Jan 31, 2018·Frontiers in Immunology·Chang XiaXiaoquan Rao
Jul 30, 2020·Cancers·Chantal AllgöwerJohannes Lemke
Oct 6, 2020·Frontiers in Physiology·Alexandra NjegicElizabeth J Cartwright

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Journal of Cardiovascular Translational Research
David RohdePatrick Most
The Canadian Journal of Cardiology
Jean-Francois DesjardinsThomas Parker
© 2022 Meta ULC. All rights reserved